Need Tally
for Clients?

Contact Us! Here

  Tally Auditor

License (Renewal)
  Tally Gold

License Renewal

  Tally Silver

License Renewal
  Tally Silver

New Licence
  Tally Gold

New Licence
 
Open DEMAT Account with in 24 Hrs and start investing now!
« From the Courts »
Open DEMAT Account in 24 hrs
 Income Tax Addition Made Towards Unsubstantiated Share Capital Is Eligible For Section 80-IC Deduction: Delhi High Court

Udit Kalra vs. ITO (Delhi High Court)
April, 03rd 2019

S. 10(38) Bogus Capital Gains from Penny Stocks: It is intriguing is that the company had meagre resources and reported consistent losses. The astronomical growth of the value of company’s shares naturally excited the suspicions of the Revenue. The company was even directed to be delisted from the stock exchange. The assessee’s argument that he was denied the right to cross-examine the individuals whose statements led to the inquiry and ultimate disallowance of the long term capital gain claim is not relevant in the wake of findings of fact

The assessee is aggrieved by the concurrent findings of the tax
authorities – including the lower appellate authorities rejecting its
claim for a long term capital gain reported by it, to the tune of
Rs.13,33,956/- and Rs.14,34,501/- in respect of 4,000 shares of M/s
Kappac Pharma Ltd. The assessee held those shares for approximately
19 months; the acquisition price was Rs.12/- per share whereas the
market price of the shares at the time of their sale, was Rs.720/-. It is
contended that the assessee was not granted fair opportunity.

Mr. Rajesh Mahna, learned counsel appearing for the assessee
relied upon the orders of the co-ordinate Bench of the tribunal, in
respect of the same company i.e. M/s Kappac Pharma Ltd., and
pointed out that the tax authority’s approach in this case was entirely
erroneous and inconsistent.

The main thrust of the assessee’s argument is that he was denied
the right to cross-examination of the two individuals whose statements
led to the inquiry and ultimate disallowance of the long term capital
gain claim in the returns which are the subject matter of the present
appeal.

This court has considered the submissions of the parties. Aside
from the fact that the findings in this case are entirely concurrent –
A.O., CIT(A) and the ITAT have all consistently rendered adverse
findings – what is intriguing is that the company (M/s Kappac Pharma
Ltd.) had meagre resources and in fact reported consistent losses. In
these circumstances, the astronomical growth of the value of
company’s shares naturally excited the suspicions of the Revenue.

The company was even directed to be delisted from the stock
exchange. Having regard to these circumstances and principally on
the ground that the findings are entirely of fact, this court is of the
opinion that no substantial question of law arises in the present appeal.
This appeal is accordingly dismissed.

Home | About Us | Terms and Conditions | Contact Us
Copyright 2024 CAinINDIA All Right Reserved.
Designed and Developed by Ritz Consulting